Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells

Rowland, J.G.; Robson, J.L.; Simon, J.W.; Leung, H.Y.; Slabas, A.R.

doi:10.1002/pmic.200600697

All Outputs (2)

Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients (2007)
Journal Article
Tompson, W., Ruiz-Perez, V. L., Blair, H. J., Barton, S., Navarro, V., Robson, J. L., …Goodship, J. A. (2007). Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients. Human Genetics, 120(5), 663-670. https://doi.org/10.1007/s00439-006-0237-7

Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells (2007)
Journal Article
Rowland, J., Robson, J., Simon, J., Leung, H., & Slabas, A. (2007). Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells. Proteomics, 7(1), 47-63. https://doi.org/10.1002/pmic.200600697

Proteins responsive to androgen and anti-androgen may be involved in the development and progression of prostate cancer and the ultimate failure of androgen-ablation therapy. These proteins represent potential diagnostic and therapeutic targets for i... Read More about Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells.